Citius Oncology, Inc. CTOR Accrued taxes and other expenses
Accrued taxes and other expenses at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrentAndNoncurrent.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s accrued taxes and other expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s accrued taxes and other expenses?
- Citius Oncology, Inc. (CTOR) reported accrued taxes and other expenses of $4.06M in Q1 2026.